These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10411384)

  • 1. Metabolic bone disease.
    Menkès CJ
    Curr Opin Rheumatol; 1999 Jul; 11(4):293. PubMed ID: 10411384
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone changes in metabolic bone disease.
    Eriksen EF; Langdahl B
    Acta Orthop Scand Suppl; 1995 Oct; 266():195-201. PubMed ID: 8553852
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantitative comparison of a bone remodeling model with dual-energy X-ray absorptiometry and analysis of the inter-individual biological variability of femoral neck T-score.
    Santos L; Romeu JC; Canhão H; Fonseca JE; Fernandes PR
    J Biomech; 2010 Dec; 43(16):3150-5. PubMed ID: 20739024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
    Li F; Yang X; Bi J; Yang Z; Zhang C
    Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between the bone mass of athletes and biochemical and genetic markers of bone tissue remodeling].
    Oganov VS; Vinogradova OL; Dudov NS; Baranov VS; Minenkov AS; Bakulin AV; Novikov VE; Kabitskaia OE; Moskalenko MV; Glotov AS; Glotov OS; Popov DV
    Fiziol Cheloveka; 2008; 34(2):56-65. PubMed ID: 18472573
    [No Abstract]   [Full Text] [Related]  

  • 6. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of osteopenia/osteoporosis by bone mineral density test using DXA method in early adulthood-a pre-emptive step towards future bone health.
    Salehi-Abari I
    Int J Rheum Dis; 2017 Jan; 20(1):122-125. PubMed ID: 25955954
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone biology and the role of the RANK ligand pathway.
    Murthy RK; Morrow PK; Theriault RL
    Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):9-15. PubMed ID: 20128323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual photon absorptiometry].
    Ochi H; Okamura T; Hagiwara S; Morii H
    Rinsho Hoshasen; 1990 Jan; 35(1):33-40. PubMed ID: 2313920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal influences on bone remodeling and bone loss: application to the management of primary hyperparathyroidism.
    Parfitt AM
    Ann Intern Med; 1996 Sep; 125(5):413-5. PubMed ID: 8702093
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytokines, growth factors, and metabolic bone disease].
    Pumarino H; Pumarino MG
    Rev Med Chil; 1996 Feb; 124(2):248-57. PubMed ID: 9213895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oestrogen receptor in bone-evolution of our knowledge.
    Lindsay R
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():16-8; discussion 18-9. PubMed ID: 8624336
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone physiology and therapeutics in chronic critical illness.
    Via MA; Gallagher EJ; Mechanick JI
    Ann N Y Acad Sci; 2010 Nov; 1211():85-94. PubMed ID: 21062297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Roentgen-morphometry and photon absorptiometry studies in normal subjects and patients with metabolic bone diseases].
    Kollin E; Varga P
    Orv Hetil; 1985 Sep; 126(35):2153-9. PubMed ID: 4034200
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bone mineral density and bone turnover in systemic sclerosis].
    Alexandersson BT; Geirsson AJ; Olafsson I; Franzson L; Sigurdsson G; Gudbjornsson B
    Laeknabladid; 2007; 93(7-8):535-41. PubMed ID: 17823496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis a disease requiring treatment or a physiologic osteopenia state? WHO definition in opposition to Utah Paradigm?].
    Frost HM; Schneider P; Schneider R
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2570-4. PubMed ID: 12457328
    [No Abstract]   [Full Text] [Related]  

  • 18. Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis.
    Hodgson SF; Dickson ER; Eastell R; Eriksen EF; Bryant SC; Riggs BL
    Bone; 1993; 14(6):819-27. PubMed ID: 8155404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bones of today, bones of tomorrow.
    Kreipe RE
    Am J Dis Child; 1992 Jan; 146(1):22-5. PubMed ID: 1736644
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention and treatment of osteoporosis in inflammatory bowel disease.
    Lichtenstein GR; Sands BE; Pazianas M
    Inflamm Bowel Dis; 2006 Aug; 12(8):797-813. PubMed ID: 16917235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.